Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?
about
Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trialsDescribing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.Clinical Recommendations for the Use of Donepezil 23 mg in Moderate-to-Severe Alzheimer's Disease in the Asia-Pacific RegionDevelopment of a new assessment scale for measuring interaction during staff-assisted transfer of residents in dementia special care units.[Cognitive stimulation and music intervention for people with dementia in nursing homes: A pilot study, problems and perspectives].Activities of daily living in dementia: revalidation of the E-ADL Test and suggestions for further developmentA Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementiasA hybrid intelligent diagnosis approach for quick screening of Alzheimer's disease based on multiple neuropsychological rating scales.Biomarkers to measure treatment effects in Alzheimer's disease: what should we look for?Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice.Establishing Clinical Relevance in Preclinical Alzheimer's Disease.Validation of the Erlangen Test of Activities of Daily Living in Persons with Mild Dementia or Mild Cognitive Impairment (ETAM)The relationship between functional status and judgment/problem solving among individuals with dementia.Methodological Aspects of the Phase II Study AFF006 Evaluating Amyloid-beta -Targeting Vaccine AFFITOPE® AD02 in Early Alzheimer's Disease - Prospective Use of Novel Composite ScalesA Psychometric Evaluation of the Threadgold Communication Tool for Persons with Dementia.Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors.The CARES(®) Observational Tool: a valid and reliable instrument to assess person-centered dementia care.Degradation in intrinsic connectivity networks across the Alzheimer's disease spectrum.Exploring the affective dimension of the life review process: Facilitators' interactional strategies for fostering personhood and social value among older adults with early dementia.Cognitive Stimulation for People with Dementia in Long-Term Care Facilities: Baseline Cognitive Level Predicts Cognitive Gains, Moderated by Depression.Impact of a cognitive rehabilitation intervention on neuropsychiatric symptoms in mild to moderate Alzheimer's disease.An approach for estimating item sensitivity to within-person change over time: An illustration using the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog).'Two-level' measurements of processing speed as cognitive markers in the differential diagnosis of DSM-5 mild neurocognitive disorders (NCD).The clinical efficacy of reminiscence therapy in patients with mild-to-moderate Alzheimer disease: Study protocol for a randomized parallel-design controlled trial.Emotional function in dementia patients.It is not only memory: effects of sensecam on improving well-being in patients with mild alzheimer disease.Clinical Pharmacokinetics and Pharmacodynamics of Drugs in the Central Nervous System.Validation of the multimodal assessment of capacities in severe dementia: a novel cognitive and functional scale for use in severe dementia.ABC Dementia Scale: A Quick Assessment Tool for Determining Alzheimer's Disease Severity.
P2860
Q21090712-2D613A2C-914E-4EA6-896B-BCAA0E093598Q27333816-6294AE54-3ED9-460C-920C-183CFD0CA734Q28067006-B3DCD400-826A-438E-ADF4-88EE32BC353FQ30204099-F92B1C01-B2FE-4F16-B15F-547D5045B65BQ30363342-3AD9CCF2-5CDA-4A55-827D-87055FCBD63DQ30537899-FBF01634-C359-42BD-8514-F49B4030F7FCQ33165693-D6DC332F-847D-4D55-B51E-743FC53E1EC8Q34528182-04EC065E-449D-4B66-A56A-FBD3383333ABQ35178023-FEA818F2-8FFD-4123-B7B1-2619099185B8Q35417970-2C748455-D78B-4E66-8A3A-3625125F75F2Q35557603-5F5880B1-577A-4B8B-BF58-E443BB20A7C1Q35911118-77332A9B-627F-4959-947B-E3FFA75E51ABQ36031400-F7F3E93F-D6F7-4801-B793-61CB07BA0967Q36395135-C9D34D5B-C96E-4704-B6FF-83E9549E8790Q36558187-E1F8A512-80F0-499C-A30D-BC2404584CCFQ36938352-885A645C-E53A-49D0-95EC-905B965481F6Q37084847-9AB5A199-D117-40FA-ADF5-A36DD2075A83Q37532921-AF5538E8-5FC9-4A45-AC3E-79AD9BAC7FC4Q37544189-EF2FFF7B-C7AC-4305-B976-C5E8A2C0DA76Q38171435-AD5FD87C-2F96-4714-96EF-CC6A28F0E2E0Q38833836-80AC8A43-7C5A-45E3-B0AC-1F5C7DD80B65Q39113775-2DAC26C1-58B0-47A9-A3FF-1AE974767145Q39862371-56144718-F9F6-4905-9178-EC19565AEF2BQ42238057-2A12AD81-0909-48A4-AD34-653A0F2CF385Q47549748-1B55B946-C904-4145-B5F2-0793F3734BEEQ47810336-63750F6D-7241-481F-B3CB-57689F0C9D83Q47985181-AC97B280-8120-4DF2-BADD-555E2B8AAD18Q49721453-71848C3D-D4A7-4AD8-852F-077ADDFA8858Q50595097-2636AEC5-DCDA-49EF-9824-C4FE555DE03CQ54934782-4F5FE00C-0132-433F-8EF9-8ED649B9C119
P2860
Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Review of Alzheimer's disease ...... valuation in medical practice?
@ast
Review of Alzheimer's disease ...... valuation in medical practice?
@en
type
label
Review of Alzheimer's disease ...... valuation in medical practice?
@ast
Review of Alzheimer's disease ...... valuation in medical practice?
@en
prefLabel
Review of Alzheimer's disease ...... valuation in medical practice?
@ast
Review of Alzheimer's disease ...... valuation in medical practice?
@en
P2093
P2860
P356
P1476
Review of Alzheimer's disease ...... valuation in medical practice?
@en
P2093
Frank Tennigkeit
Philippe Robert
Serge Gauthier
P2860
P2888
P356
10.1186/ALZRT48
P407
P577
2010-08-26T00:00:00Z
P5875
P6179
1031951220